1. Home
  2. FEIM vs BNTC Comparison

FEIM vs BNTC Comparison

Compare FEIM & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEIM
  • BNTC
  • Stock Information
  • Founded
  • FEIM 1961
  • BNTC 1995
  • Country
  • FEIM United States
  • BNTC United States
  • Employees
  • FEIM N/A
  • BNTC N/A
  • Industry
  • FEIM Electrical Products
  • BNTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEIM Industrials
  • BNTC Health Care
  • Exchange
  • FEIM Nasdaq
  • BNTC Nasdaq
  • Market Cap
  • FEIM 291.0M
  • BNTC 365.1M
  • IPO Year
  • FEIM N/A
  • BNTC N/A
  • Fundamental
  • Price
  • FEIM $36.76
  • BNTC $16.09
  • Analyst Decision
  • FEIM Strong Buy
  • BNTC Strong Buy
  • Analyst Count
  • FEIM 1
  • BNTC 5
  • Target Price
  • FEIM $43.00
  • BNTC $24.80
  • AVG Volume (30 Days)
  • FEIM 262.2K
  • BNTC 66.2K
  • Earning Date
  • FEIM 12-09-2025
  • BNTC 11-13-2025
  • Dividend Yield
  • FEIM N/A
  • BNTC N/A
  • EPS Growth
  • FEIM 264.74
  • BNTC N/A
  • EPS
  • FEIM 2.27
  • BNTC N/A
  • Revenue
  • FEIM $68,546,000.00
  • BNTC N/A
  • Revenue This Year
  • FEIM N/A
  • BNTC N/A
  • Revenue Next Year
  • FEIM $17.90
  • BNTC N/A
  • P/E Ratio
  • FEIM $16.39
  • BNTC N/A
  • Revenue Growth
  • FEIM 18.30
  • BNTC N/A
  • 52 Week Low
  • FEIM $12.34
  • BNTC $9.10
  • 52 Week High
  • FEIM $41.12
  • BNTC $17.15
  • Technical
  • Relative Strength Index (RSI)
  • FEIM 52.94
  • BNTC 61.78
  • Support Level
  • FEIM $36.61
  • BNTC $15.20
  • Resistance Level
  • FEIM $41.07
  • BNTC $16.67
  • Average True Range (ATR)
  • FEIM 2.57
  • BNTC 0.82
  • MACD
  • FEIM -0.22
  • BNTC 0.01
  • Stochastic Oscillator
  • FEIM 42.65
  • BNTC 69.27

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: